A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

January 31, 2006

Study Completion Date

February 29, 2008

Conditions

Psoriasis

Interventions

DRUG

Masitinib

6 mg/kg/day

DRUG

Masitinib

3 mg/kg/day

DRUG

Placebo

Placebo matching masitinib (3 mg/kg/day and 6 mg/kg/day)